دورية أكاديمية
أعرض في EDS

Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19.

التفاصيل البيبلوغرافية
العنوان: Keratoplasty rejection after messenger RNA vaccine (BNT162b2) for COVID-19.
المؤلفون: Eduarda Andrade E Andrade M; Clínica Oftalmológica do Complexo Hospitalar Padre Bento de Guarulhos, Guarulhos, São Paulo, Brazil., Rodrigues JC; Clínica Oftalmológica do Complexo Hospitalar Padre Bento de Guarulhos, Guarulhos, São Paulo, Brazil., Junior EF; Clínica Oftalmológica do Complexo Hospitalar Padre Bento de Guarulhos, Guarulhos, São Paulo, Brazil., de Lima MHC; Clínica Oftalmológica do Complexo Hospitalar Padre Bento de Guarulhos, Guarulhos, São Paulo, Brazil.
المصدر: Indian journal of ophthalmology [Indian J Ophthalmol] 2022 Aug; Vol. 70 (8), pp. 3134-3136.
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print Cited Medium: Internet ISSN: 1998-3689 (Electronic) Linking ISSN: 03014738 NLM ISO Abbreviation: Indian J Ophthalmol Subsets: MEDLINE
أسماء مطبوعة: Publication: Mumbai : Medknow Publications
Original Publication: Bombay : All-India Ophthalmological Society
مواضيع طبية MeSH: BNT162 Vaccine*/adverse effects , COVID-19*/prevention & control , Corneal Transplantation* , Graft Rejection*/chemically induced, Humans ; SARS-CoV-2
مستخلص: This report shows a case of corneal transplant rejection after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), short after receiving the BNT162b2 vaccine, in a patient who had undergone keratoplasty more than 20 years ago, with no previous episodes of rejection and no other factor that could lead to the findings on his examinations. After treatment with high doses of topic, oral, and sub-conjunctival corticoids, the patient had a favorable therapeutic response. The signs of corneal transplant rejection must be oriented to the patients and the causing factors actively searched by ophthalmologists so that treatment is rapidly initiated and sequels are avoided. This report raises the question if these events are correlated and whether the patient should receive the second dose of the vaccine against SARS-CoV-2 or not.
Competing Interests: None
References: Indian J Ophthalmol. 2021 Jul;69(7):1953-1954. (PMID: 34146066)
Vaccines (Basel). 2021 Nov 03;9(11):. (PMID: 34835205)
Br J Ophthalmol. 2021 Jul;105(7):893-896. (PMID: 33910885)
Ocul Immunol Inflamm. 2010 Jun;18(3):162-71. (PMID: 20482389)
N Engl J Med. 2020 Dec 17;383(25):2439-2450. (PMID: 33053279)
JAMA Ophthalmol. 2016 Feb;134(2):167-73. (PMID: 26633035)
Cornea. 2021 Aug 1;40(8):1070-1072. (PMID: 34029238)
فهرسة مساهمة: Keywords: BNT162b2 vaccine; coronavirus; keratoplasty; penetrating; vaccine
المشرفين على المادة: N38TVC63NU (BNT162 Vaccine)
تواريخ الأحداث: Date Created: 20220803 Date Completed: 20220804 Latest Revision: 20221120
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9672786
DOI: 10.4103/ijo.IJO_1021_22
PMID: 35918988
قاعدة البيانات: MEDLINE
الوصف
تدمد:1998-3689
DOI:10.4103/ijo.IJO_1021_22